Mounir Armanious Research Center (MARC) is pleased to announce a call for proposals for projects based on innovation and excellence
Mounir Armanious Research Center (MARC) is pleased to announce a call for proposals for projects based on innovation and excellence. This grant will be awarded to high-priority basic biomedical research projects with the potential for high scientific impact and/or high user impact, addressing new concepts and techniques to improve health. EVA Pharma will provide funding not exceeding three million Egyptian pounds to the accepted project for a period of up to two years. Research projects with a focus on the following areas will be considered: • Immunotherapy in cancer and cancer research • Multidrug-resistant bacteria • NASH Applications are thoroughly reviewed by MARC ahead of scientific and technical evaluation by an independent committee. Deadline: 1 November 2021. Application form will be closed at 11:59pm Egypt Standard Time. Please read the grant guidelines and instructions before submitting an application.
For more information on the call of proposal: https://marc.evapharma.com/